Protocol for a drugs exposure pregnancy registry for implementation in resource-limited settings
<p>Abstract</p> <p>Background</p> <p>The absence of robust evidence of safety of medicines in pregnancy, particularly those for major diseases provided by public health programmes in developing countries, has resulted in cautious recommendations on their use. We describ...
Main Authors: | Mehta Ushma, Clerk Christine, Allen Elizabeth, Yore Mackensie, Sevene Esperança, Singlovic Jan, Petzold Max, Mangiaterra Viviana, Elefant Elizabeth, Sullivan Frank M, Holmes Lewis B, Gomes Melba |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-09-01
|
Series: | BMC Pregnancy and Childbirth |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2393/12/89 |
Similar Items
-
Antibiotic use amongst pregnant women in a public hospital in KwaZulu-Natal
by: Sasha Naidoo, et al.
Published: (2021-05-01) -
Birth outcomes following antiretroviral exposure during pregnancy: Initial results from a pregnancy exposure registry in South Africa
by: Ushma C. Mehta, et al.
Published: (2019-09-01) -
Drug‐related teratogenic and pathologic causes of birth defects in a tertiary hospital in Southwestern Nigeria
by: Ifeanyichukwu Offor, et al.
Published: (2019-02-01) -
The necessity of establishment of Craniofacial Anomalies Registry in Iran
by: Mohammad Bayat, et al.
Published: (2015-10-01) -
PREEXISTING MATERNAL DISORDERS – RISK FACTORS FOR NEWBORN CONGENITAL ANOMALIES
by: Elena Braha, et al.
Published: (2016-06-01)